These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6212596

  • 1. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN, Gavan TL, Barry AL, Thornsberry C, Gibbs DL.
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [Abstract] [Full Text] [Related]

  • 2. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.
    Thornsberry C, Barry AL, Jones RN, Baker CN, Badal RE.
    J Clin Microbiol; 1982 May; 15(5):769-76. PubMed ID: 6212595
    [Abstract] [Full Text] [Related]

  • 3. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
    Jones RN, Barry AL, Thornsberry C.
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
    [Abstract] [Full Text] [Related]

  • 4. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC, Jones RN, Barry AL, Gavan TL.
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [Abstract] [Full Text] [Related]

  • 5. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
    Kronvall G.
    J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
    [Abstract] [Full Text] [Related]

  • 6. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
    Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
    [Abstract] [Full Text] [Related]

  • 7. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
    Wright DN, Welch DF, Saxon BA, Clark SJ, Matsen JM.
    Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
    [Abstract] [Full Text] [Related]

  • 8. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
    Barry AL, Jones RN, Thornsberry C.
    Antimicrob Agents Chemother; 1981 Oct; 20(4):525-9. PubMed ID: 6211134
    [Abstract] [Full Text] [Related]

  • 9. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
    Jones RN, Barry AL, Thornsberry C, Wilson HW.
    Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
    [Abstract] [Full Text] [Related]

  • 10. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L, Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [Abstract] [Full Text] [Related]

  • 11. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
    Barry AL, Thornsberry C, Jones RN, Gavan TL.
    J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833
    [Abstract] [Full Text] [Related]

  • 12. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 13. Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.
    Bradford PA, Sanders CC.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):394-400. PubMed ID: 1605604
    [Abstract] [Full Text] [Related]

  • 14. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
    Jones RN, Barry AL.
    J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
    [Abstract] [Full Text] [Related]

  • 15. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
    Barry AL, Gavan TL, Thornsberry C, Jones RN.
    J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
    [Abstract] [Full Text] [Related]

  • 16. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
    Barry AL, Thornsberry C, Jones RN, Gavan TL.
    Rev Infect Dis; 1985 Oct; 7 Suppl 4():S594-604. PubMed ID: 3909316
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL, Jones RN, Thornsberry C.
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [Abstract] [Full Text] [Related]

  • 18. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL, Glenn S, DiPersio JR, Leist PA.
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [Abstract] [Full Text] [Related]

  • 19. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH, Swenson JM, Tenover FC, Barry A, Ferraro MJ, Murray PR, Reller LB.
    J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
    [Abstract] [Full Text] [Related]

  • 20. Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
    Barry AL, Miller GH, Hare RS, Jones RN, Thornsberry C.
    J Clin Microbiol; 1984 Mar; 19(3):311-4. PubMed ID: 6425354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.